72
Participants
Start Date
February 28, 2006
Primary Completion Date
July 31, 2009
Study Completion Date
August 31, 2010
ulipristal acetate 20 mg
ulipristal acetate at a daily dose of 20 mg, given once daily for three menstrual cycles or 90 - 102 days if amenorrheic
ulipristal acetate 10 mg
10 mg given daily for three menstrual cycles or 90 - 102 days
placebo
placebo given once daily for 3 menstrual cycles or 90 - 102 days
NIH Clinical Center, Bethesda
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda
Collaborators (1)
HRA Pharma
INDUSTRY
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH